Lobbying Relationship

Client

Amgen, Inc.

More records

Lobbying firm

Dow Lohnes Government Strategies LLC

More records

  • Medicare coverage and reimbursement, including H.R. 1894, H.R. 3590 - Patient Protection and Affordable Care Act, and related legislation (provisions related to Medicare coverage and reimbursement for DXA testing).
  • H.R. 1427 - Promoting Innovation and Access to Life Saving Medicine Act, H.R. 1548 - Pathway for Biosimilar Act, and H.R. 3590 - Patient Protection and Affordable Care Act (provisions related to biosimilars).

Duration: to

General Issues: Medicare/Medicaid, Health Issues

Spending: about $340,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: House of Representatives,, House of Representatives, U.S. Senate

Affiliated organizations: Dow Lohnes PLLC

Bills mentioned

H.R.1894: Medicare Fracture Prevention and Osteoporosis Testing Act of 2009

Sponsor: Shelley Berkley (D-Nev.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.1392: To amend title XVIII of the Social Security Act to ensure more...

Sponsor: Gene Green (D-Texas)

H.R.1038: Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007

Sponsor: Jay Inslee (D-Wash.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Eric S. Kessler Chief of Staff, Hon. John D. Dingell
Peter A. Leon Legislative Director, Hon. Eliot Engel
Jessica M. Lenard Legislative Assistant, Hon. Richard J. Durbin

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page